Your browser doesn't support javascript.
loading
Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis.
Liu, Xiangxing; Zhang, Jiaojiao; Feng, Keqing; Wang, Simin; Chen, Liming; Niu, Suping; Lu, Qian; Fang, Yi.
Affiliation
  • Liu X; Department of Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Zhang J; Department of Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Feng K; Department of Clinical Pharmacy, Ocean University of China, Qingdao, China.
  • Wang S; Department of Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Chen L; Nursing Department, Peking University People's Hospital, Beijing, China.
  • Niu S; Clinical Trial Institution, Scientific Research Department, Peking University People's Hospital, Beijing, China.
  • Lu Q; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Fang Y; Clinical Trial Institution, Peking University People's Hospital, Beijing, China.
Front Pharmacol ; 13: 1023533, 2022.
Article in En | MEDLINE | ID: mdl-36452227

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: Country of publication: